The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease

M.M. Harnett, A.J. Melendez, W. Harnett

Research output: Contribution to journalArticle

52 Citations (Scopus)
58 Downloads (Pure)

Abstract

The dramatic recent rise in the incidence of allergic or autoimmune inflammatory diseases in the West has been proposed to reflect the lack of appropriate priming of the immune response by infectious agents such as parasitic worms during childhood. Consistent with this, there is increasing evidence supporting an inverse relationship between worm infection and T helper type 1/17 (Th1/17)-based inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes and multiple sclerosis. Perhaps more surprisingly, given that such worms often induce strong Th2-type immune responses, there also appears to be an inverse correlation between parasite load and atopy. These findings therefore suggest that the co-evolution of helminths with hosts, which has resulted in the ability of worms to modulate inflammatory responses to promote parasite survival, has also produced the benefit of protecting the host from pathological lesions arising from aggressive proinflammatory responses to infection or, indeed, aberrant inflammatory responses underlying autoimmune and allergic disorders. By focusing upon the properties of the filarial nematode-derived immunomodulatory molecule, ES-62, in this review we shall discuss the potential of exploiting the immunomodulatory products of parasitic worms to identify and develop novel therapeutics for inflammation.

Original languageEnglish
Pages (from-to)256-67
Number of pages12
JournalClinical and Experimental Immunology
Volume159
Issue number3
Early online date1 Dec 2009
DOIs
Publication statusPublished - Mar 2010

Keywords

  • allergy
  • autoimmune disease
  • ES-62
  • immunomodulation
  • inflammation
  • nematodes

Cite this